TSMC to Hike Chip Prices by Up to 10% in 2027, Nikkei Says

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

TSMC expects 'strong, multi-year' demand for AI chips as it ramps up Arizona investment

TSMC is accelerating Arizona factory buildout to capitalize on AI ‘megatrend,’ CFO says